These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 18467771)

  • 1. Structural considerations for designing adenosine analogs as selective inhibitors of Trichomonas sp. glyceraldehyde-3- phosphate dehydrogenase.
    Kundu S; Roy D
    In Silico Biol; 2007; 7(6):583-93. PubMed ID: 18467771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational changes in Leishmania mexicana glyceraldehyde-3-phosphate dehydrogenase induced by designed inhibitors.
    Suresh S; Bressi JC; Kennedy KJ; Verlinde CL; Gelb MH; Hol WG
    J Mol Biol; 2001 Jun; 309(2):423-35. PubMed ID: 11371162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective tight binding inhibitors of trypanosomal glyceraldehyde-3-phosphate dehydrogenase via structure-based drug design.
    Aronov AM; Verlinde CL; Hol WG; Gelb MH
    J Med Chem; 1998 Nov; 41(24):4790-9. PubMed ID: 9822549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational study of glyceraldehyde-3-phosphate dehydrogenase of Entamoeba histolytica: implications for structure-based drug design.
    Kundu S; Roy D
    J Biomol Struct Dyn; 2007 Aug; 25(1):25-33. PubMed ID: 17676935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural analysis of human liver glyceraldehyde-3-phosphate dehydrogenase.
    Ismail SA; Park HW
    Acta Crystallogr D Biol Crystallogr; 2005 Nov; 61(Pt 11):1508-13. PubMed ID: 16239728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based design of submicromolar, biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase.
    Aronov AM; Suresh S; Buckner FS; Van Voorhis WC; Verlinde CL; Opperdoes FR; Hol WG; Gelb MH
    Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4273-8. PubMed ID: 10200252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of trypanosomal glyceraldehyde-3-phosphate dehydrogenase by protein structure-based design: toward new drugs for the treatment of sleeping sickness.
    Verlinde CL; Callens M; Van Calenbergh S; Van Aerschot A; Herdewijn P; Hannaert V; Michels PA; Opperdoes FR; Hol WG
    J Med Chem; 1994 Oct; 37(21):3605-13. PubMed ID: 7932587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of nicotinamide adenine dinucleotide kinases by dinucleoside disulfide mimics of nicotinamide adenine dinucleotide analogues.
    Petrelli R; Sham YY; Chen L; Felczak K; Bennett E; Wilson D; Aldrich C; Yu JS; Cappellacci L; Franchetti P; Grifantini M; Mazzola F; Di Stefano M; Magni G; Pankiewicz KW
    Bioorg Med Chem; 2009 Aug; 17(15):5656-64. PubMed ID: 19596199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for selective inhibition of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase: molecular docking and 3D QSAR studies.
    Guido RV; Oliva G; Montanari CA; Andricopulo AD
    J Chem Inf Model; 2008 Apr; 48(4):918-29. PubMed ID: 18303835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural considerations for the rational design of selective anti-trypanosomal agents: the role of the aromatic clusters at the interface of triosephosphate isomerase dimer.
    Espinoza-Fonseca LM; Trujillo-Ferrara JG
    Biochem Biophys Res Commun; 2005 Mar; 328(4):922-8. PubMed ID: 15707966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of glyceraldehyde-3-phosphate dehydrogenase from Plasmodium falciparum.
    Satchell JF; Malby RL; Luo CS; Adisa A; Alpyurek AE; Klonis N; Smith BJ; Tilley L; Colman PM
    Acta Crystallogr D Biol Crystallogr; 2005 Sep; 61(Pt 9):1213-21. PubMed ID: 16131754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship for nucleoside analogs as inhibitors or substrates of adenosine kinase from Mycobacterium tuberculosis. I. Modifications to the adenine moiety.
    Long MC; Parker WB
    Biochem Pharmacol; 2006 Jun; 71(12):1671-82. PubMed ID: 16620788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analyses of Plasmodium falciparum and human S-adenosylhomocysteine hydrolases.
    Nakanishi M; Yabe S; Tanaka N; Ito Y; Nakamura KT; Kitade Y
    Mol Biochem Parasitol; 2005 Oct; 143(2):146-51. PubMed ID: 16005528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationships of analogs of 2'-deoxy-2'-(3-methoxybenzamido)adenosine, a selective inhibitor of trypanosomal glycosomal glyceraldehyde-3-phosphate dehydrogenase.
    Van Calenbergh S; Verlinde CL; Soenens J; De Bruyn A; Callens M; Blaton NM; Peeters OM; Rozenski J; Hol WG; Herdewijn P
    J Med Chem; 1995 Sep; 38(19):3838-49. PubMed ID: 7562915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
    Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
    J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theoretical study of inhibition of adenosine deaminase by (8R)-coformycin and (8R)-deoxycoformycin.
    Marrone TJ; Straatsma TP; Briggs JM; Wilson DK; Quiocho FA; McCammon JA
    J Med Chem; 1996 Jan; 39(1):277-84. PubMed ID: 8568817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure analysis and in silico pKa calculations suggest strong pKa shifts of ligands as driving force for high-affinity binding to TGT.
    Ritschel T; Hoertner S; Heine A; Diederich F; Klebe G
    Chembiochem; 2009 Mar; 10(4):716-27. PubMed ID: 19199329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase inhibitors.
    Freitas RF; Prokopczyk IM; Zottis A; Oliva G; Andricopulo AD; Trevisan MT; Vilegas W; Silva MG; Montanari CA
    Bioorg Med Chem; 2009 Mar; 17(6):2476-82. PubMed ID: 19254846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies on inhibitors of HIV protease: a target for drug design.
    Jayaraman S; Shah K
    In Silico Biol; 2008; 8(5-6):427-47. PubMed ID: 19374129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural analysis of ARC-type inhibitor (ARC-1034) binding to protein kinase A catalytic subunit and rational design of bisubstrate analogue inhibitors of basophilic protein kinases.
    Lavogina D; Lust M; Viil I; König N; Raidaru G; Rogozina J; Enkvist E; Uri A; Bossemeyer D
    J Med Chem; 2009 Jan; 52(2):308-21. PubMed ID: 19143565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.